Veritas and Cannevert Complete Prestudy Visit of the Puerto Rico Clinical Trial Facility
Dec 29, 2017 | News
December 29, 2017, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), (“Veritas” or the “Company”) announces that its has completed a prestudy visit of the Fundación de Investigación (FDI) facilities in San Juan, Puerto Rico. This will be the site where the Company’s research arm, Cannevert Therapeutics Ltd. (“CTL“) will be conducting its first human study of CTL-X, a cannabis strain targeting pain management.
...
Quelle: veritaspharmainc.com/2017/12/29/...co-clinical-trial-facility/